Compositions and methods for the treatment of hemoglobinopathies
The present invention is directed to genome editing systems, reagents and methods for the treatment of hemoglobinopathies.
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
11.10.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention is directed to genome editing systems, reagents and methods for the treatment of hemoglobinopathies. |
---|---|
Bibliography: | Application Number: US201816484046 |